Group 1 - The core point of the article is that Jinhao Medical will face a lock-up expiration of 540,000 shares next week, with a market value of approximately 7.38 million yuan, accounting for 0.98% of the pre-expiration circulating market value [1] - The lock-up shares are from equity incentive plans, and the expiration date is set for April 28, 2025 [1] - The shareholders involved in this lock-up expiration include multiple individuals, each holding varying amounts of shares, with the largest individual holdings being 28,000 shares [2] Group 2 - As of the report, Jinhao Medical's stock price is 13.74 yuan, reflecting an increase of 0.51%, with a circulating market value of 760 million yuan and a total market value of 1.342 billion yuan [3] - Jinhao Medical operates in sectors such as medical devices, Guangdong region, specialized and innovative enterprises, margin trading, and medical device concepts [3] - Founded in 2011, Jinhao Medical is recognized as a high-tech enterprise in Guangdong and has received various international awards for its hearing aid products, including the German Red Dot Design Award [4] - The company focuses on the research, production, and sales of hearing aids and has obtained certifications such as FDA and CE, establishing partnerships with major international retailers [4] - Jinhao Medical aims to become a leader in both domestic and international markets, expanding its reach to provide hearing solutions globally [4]
锦好医疗下周迎54万股解禁，市值738万，助力全球听力健康